[Treatment of severe coronary insufficiency with carbochromen].
D000787:Angina Pectoris / Q000139:chemically induced / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000517:prevention & control; D009325:Nausea / Q000139:chemically induced; D013546:Sweating / Q000187:drug effects; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D000925:Anticoagulants; D014665:Vasodilator Agents
Die Behandlung der schweren Coronarinsuffizienz mit Carbochromen.